We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Medlab Middle East Looks to The Future of Laboratories

By LabMedica International staff writers
Posted on 24 Jan 2025

The medical laboratory market in the Middle East and Africa (MEA) is expected to experience substantial growth, with projections indicating it could reach USD 473. More...

84 million by 2029, growing at a strong Compound Annual Growth Rate (CAGR) of 12.6%. Against this promising backdrop, Medlab Middle East (Dubai, UAE), organized by Informa Markets (London, UK), will take place from February 3-6, 2024, in Dubai, UAE. This event will gather medical laboratory professionals and industry leaders to discuss the future of laboratories and their transformative impact on healthcare both regionally and globally. The 2025 edition of Medlab Middle East will focus on the theme "Empowering today’s medical labs for tomorrow’s global future." Key product categories showcased will include disposable products, medical equipment, IT, pharma/nutrition, and lab services. Medlab Middle East 2024 generated an impressive USD 670 million in business, reinforcing its significance in the global healthcare sector.

Medical laboratories play a vital role in the healthcare system, providing diagnostic and testing services that are critical for disease identification, monitoring, and treatment decisions. With an increasing prevalence of chronic and non-communicable diseases, a growing population, and mandatory healthcare and insurance coverage in the MEA region, the demand for medical laboratory services has surged. Technologies in medical labs enhance the ability to collect and analyze patient health data, leading to more accurate, personalized diagnoses and treatment, ultimately improving patient outcomes, reducing costs, and increasing accessibility.

Recent technological advances have significantly improved healthcare, with key innovations including Next-Generation Sequencing (NGS), Point-of-Care Testing (POCT), and 3D Printing. Artificial Intelligence (AI) and machine learning are also making their mark in medical lab technology, enabling data analytics and predictive algorithms to improve diagnoses and patient care. At Medlab Middle East, global laboratory leaders such as Abbott, Beckman Coulter, Randox, and Sansure will showcase their latest innovations. Sansure will present the IPonatic III Pro, a POCT solution that utilizes magnetic extraction technology to overcome the limitations of traditional PCR methods and offer fast, reliable results.

Beckman Coulter will display the DxC 500 AU Chemistry Analyzer to optimize lab operations and the Dxl 9000 Access Immunoassay Analyzer to meet increased diagnostic demand. Randox will unveil the Acusera Smart Range, which simplifies stock management, reduces inventory, and saves time for laboratories. The Medlab Middle East Congress will feature over 150 world-class speakers and offer 12 CME-accredited conference tracks covering topics like Lab Management, Clinical Chemistry, Hematology, Clinical Microbiology, Molecular Diagnostics, and more. New this year, Thought Leadership Forums will focus on Women’s Health and Precision Medicine. The Global Lab Leaders Breakfast Forum, set for days two and three of the event, will bring together experts and stakeholders to drive advancements in laboratory practices globally.

“Now in its 24th edition, Medlab Middle East showcases the forefront of laboratory technology and innovation, attracting global leaders, pioneers, and industry experts,” said Tom Coleman, Group Exhibition Director, Informa Markets Healthcare. “The event offers a premier platform for experiencing groundbreaking discoveries, exploring cutting-edge solutions, and engaging in invaluable networking opportunities.”

Related Links:
Medlab Middle East
Informa Markets


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Urine Drug Test
Instant-view® Phencyclidine Urine Drug Test
New
Glucose Tolerance Test
NERL Trutol
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: Microscopy image of invasive breast cancer cells degrading their underlying extracellular matrix (Photo courtesy of University of Turku)

Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues

Patients with breast cancer who progress from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) face a significantly worse prognosis, as metastatic disease remains incurable.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.